PharmaNet Ltd

PharmaNet Development Group, Inc., an inVentiv Health Company, a recognized leader of global drug development services to the pharmaceutical, biotechnology, generic drug, and medical device industries, provides comprehensive capabilities in Phase I-IV clinical development, bioanalytical and bioequivalence services, regulatory, contract staffing, and therapeutic solutions. With a global presence in 32 countries, Pharmanet can conduct clinical trials of any size; from a single local study to global programs spanning multiple continents with the confidence that local expertise affords.

From Phase 1 to post-approval, we can provide strategic guidance for every phase of development. With an exceptional team of former senior-level FDA officials, and other international regulatory and pharmaceutical consultants experienced in clinical development, we have the necessary experts in generic development and insights into biosimilar regulatory issues for your small or large molecule development program.

Our services include strategic planning, assay development/validation, sample analysis, immunogenicity testing, bioequivalence studies, Phase I-IV Programs, product development and process strategy, regulatory consulting and filing services, including 505(b)2.

For the applied knowledge and intelligent solutions for your next drug development program, PharmaNet works for you. For more information, please visit http://www.pharmanet-i3.com/